GO:0062089 regulation of taurine biosynthetic process: Metabolic Control Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0062089 describes any process that modulates the rate, frequency or extent of taurine biosynthesis, a biological_process ontology term.
• Taurine is a conditionally essential organic osmolyte whose cellular content is tightly regulated by synthesis, transport and catabolism.
• The taurine transporter (SLC6A6/TauT) is a key regulatory node controlling intracellular taurine availability and biosynthetic demand.
• Taurine biosynthetic regulation intersects with cysteine catabolism and N-acetyltaurine hydrolysis, linking it to feeding and obesity control [2,3].
• Dysregulated taurine homeostasis contributes to leukaemogenesis, pancreatic beta-cell senescence and tumour mitochondrial translation [1,4,5].
• CRISPR knockout, knock-in, point-mutation and overexpression models are essential to dissect causal regulation of taurine biosynthetic flux.
Description
GO:0062089, regulation of taurine biosynthetic process, is a Gene Ontology biological_process term defined as any process that modulates the rate, frequency or extent of taurine biosynthesis. Taurine (2-aminoethanesulfonic acid) is a sulfur-containing organic osmolyte that is conditionally essential in mammals and is maintained through a balance of dietary uptake, de novo synthesis from cysteine, and regulated efflux. Because taurine participates in osmoregulation, bile acid conjugation, calcium signalling and mitochondrial function, the cell must continuously adjust its biosynthetic output to match physiological demand [7,8]. Understanding how this regulation is wired is therefore central to metabolism, cancer biology and ageing research. At the cellular level, taurine content is controlled by the taurine transporter SLC6A6 (TauT), which mediates sodium- and chloride-dependent uptake and is itself subject to regulation by osmotic stress, hormones and substrate availability. The biosynthetic arm of this system converts cysteine via cysteine dioxygenase and cysteine sulfinic acid decarboxylase into hypotaurine, which is then oxidised to taurine; the rate of this pathway is modulated by cysteine catabolism and by the availability of cofactors such as pyridoxal phosphate [3,8]. Recent work has shown that N-acetyltaurine, a taurine derivative, is hydrolysed by PTER, a hydrolase that regulates feeding and obesity, directly linking taurine metabolism to systemic energy balance. For researchers, GO:0062089 provides a formal framework to annotate genes and pathways that set the rate of taurine production. Dysregulation of this process has been implicated in leukaemia, where taurine from the tumour niche drives glycolysis, in pancreatic beta-cell senescence through p53 inhibition, and in tumour growth sustained by mitochondrial taurine import. This article reviews the definition, mechanism, key genes, disease links and experimental methods used to study regulation of taurine biosynthetic process.
regulation of taurine biosynthetic process At A Glance
| GO ID | GO:0062089 |
|---|---|
| GO term | regulation of taurine biosynthetic process |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that modulates the rate, frequency or extent of taurine biosynthesis. |
| Major function | Controls the rate of taurine production to match osmotic, metabolic and signalling demand. |
| Related process | Taurine biosynthetic process (GO:0019530) and taurine transport (GO:0015734). |
| Key regulators | SLC6A6/TauT, cysteine catabolism enzymes, PTER, and osmotic stress signalling. |
| Disease relevance | Leukaemia, obesity, pancreatic beta-cell senescence and tumour metabolism [1,2,4,5]. |
What Is GO:0062089?
In our own words, GO:0062089 (regulation of taurine biosynthetic process) encompasses any molecular or cellular process that changes the rate, frequency or extent of taurine biosynthesis. It does not describe the biosynthetic reaction itself, but rather the upstream control layer: the signalling, transport, substrate supply and enzymatic modulation events that determine how much taurine a cell produces. This includes regulation of cysteine availability, modulation of biosynthetic enzyme activity, and feedback from taurine transport and catabolism [7,8].
Why Is regulation of taurine biosynthetic process Important in Cell Biology?
Regulation of taurine biosynthetic process is important because taurine is a multifunctional metabolite that protects cells against osmotic stress, supports mitochondrial translation and modulates glucose uptake, yet excessive or misplaced taurine can fuel tumour growth [1,5,6]. The rate of taurine biosynthesis must therefore be precisely tuned, and failures in this control layer are increasingly linked to cancer, metabolic disease and ageing [1,2,4,5].
• Taurine is a major organic osmolyte; its biosynthetic rate must adapt to osmotic stress to maintain cell volume.
• The taurine transporter SLC6A6 is a regulated gatekeeper of intracellular taurine and biosynthetic demand.
• Taurine from the tumour niche drives glycolysis to promote leukaemogenesis, showing that biosynthetic regulation can be hijacked in cancer.
• PTER hydrolyses N-acetyltaurine and regulates feeding and obesity, connecting taurine metabolism to energy balance.
• Covariation mass spectrometry has uncovered proteins controlling cysteine catabolism, a substrate input to taurine biosynthesis.
• Taurine alleviates pancreatic beta-cell senescence by inhibiting the p53 pathway, linking biosynthetic regulation to ageing.
• SLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth.
• Taurine regulates glucose uptake in skeletal muscle, tying biosynthetic control to systemic glucose homeostasis.
• CRISPR models allow causal testing of whether candidate regulators change taurine biosynthetic flux.
• GO:0062089 provides a standard annotation target for functional genomics and pathway enrichment studies.
What Happens During regulation of taurine biosynthetic process?
Substrate supply and cysteine catabolism
In simple terms: The cell must first make sure it has enough cysteine, the raw material for taurine.
Taurine biosynthesis depends on cysteine availability, and cysteine catabolism is a regulated entry point into the pathway. Covariation mass spectrometry has uncovered a protein that controls cysteine catabolism, demonstrating that substrate supply is actively regulated rather than passive. Because cysteine is also used for glutathione and protein synthesis, its partitioning into taurine production is a key control node for GO:0062089 [3,8].
Enzymatic conversion and cofactor availability
In simple terms: Enzymes convert cysteine step by step into taurine, and their activity can be turned up or down.
The canonical taurine biosynthetic route converts cysteine to hypotaurine and then to taurine, requiring pyridoxal phosphate-dependent decarboxylation and subsequent oxidation. The rate of these reactions is modulated by enzyme abundance, cofactor availability and redox state, all of which fall under the regulation described by GO:0062089. Because the pathway intermediates are reactive, their flux must be coordinated with cellular antioxidant defences.
Transport-mediated feedback
In simple terms: The taurine transporter controls how much taurine stays inside the cell, which feeds back on how much is made.
SLC6A6 (TauT) mediates sodium- and chloride-dependent taurine uptake and is itself regulated by osmotic stress, hormones and substrate levels. Intracellular taurine content is a balance of synthesis, uptake and efflux, and the transporter provides feedback that modulates biosynthetic rate [7,8]. In mitochondria, SLC6A6 imports taurine to sustain mitochondrial translation, adding an organelle-level layer of regulation.
Catabolism and derivative hydrolysis
In simple terms: Breakdown of taurine derivatives also affects how much taurine the cell needs to make.
PTER is an N-acetyltaurine hydrolase that regulates feeding and obesity, showing that taurine derivative catabolism is a regulated process that can influence taurine economy. By controlling the pool of N-acetyltaurine, PTER indirectly affects the demand for taurine biosynthesis and thus participates in the broader regulation captured by GO:0062089.
Integration with systemic metabolic signals
In simple terms: Whole-body signals such as feeding status and glucose levels can change how much taurine is produced.
Taurine regulates glucose uptake in skeletal muscle, and its biosynthetic regulation is therefore integrated with systemic glucose homeostasis. Feeding status and obesity-related signalling, including PTER activity, further connect taurine metabolism to whole-body energy balance. These systemic inputs ensure that taurine production matches physiological demand rather than running constitutively [2,6].
Key Genes Involved in GO:0062089 regulation of taurine biosynthetic process
The following genes and proteins are experimentally implicated in the regulation of taurine biosynthetic process or in taurine homeostasis that feeds back on it.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC6A6 | Sodium- and chloride-dependent taurine transporter (TauT) | Gatekeeper of intracellular taurine; regulates biosynthetic demand |
| PTER | N-acetyltaurine hydrolase | Links taurine derivative catabolism to feeding and obesity |
| CDO1 | Cysteine dioxygenase | Controls cysteine catabolism, a substrate input to taurine synthesis |
| CSAD | Cysteine sulfinic acid decarboxylase | Catalyses a key decarboxylation step in taurine biosynthesis |
| GADL1 | Glutamate decarboxylase-like 1 | Alternative decarboxylase implicated in taurine pathway flux |
| SLC6A6 (mitochondrial pool) | Mitochondrial taurine import | Sustains mitochondrial translation and tumour growth |
| TP53 | p53 tumour suppressor | Taurine alleviates beta-cell senescence by inhibiting p53 |
| SLC7A11 | Cystine/glutamate antiporter | Supplies cysteine for taurine and glutathione synthesis |
| GCLC | Glutamate-cysteine ligase catalytic subunit | Competes for cysteine, influencing taurine substrate availability |
| GCLM | Glutamate-cysteine ligase modifier subunit | Modulates cysteine partitioning between glutathione and taurine |
| CTH | Cystathionine gamma-lyase | Contributes to cysteine catabolism and sulfur amino acid flux |
| MTR | Methionine synthase | Supports methionine cycle input to cysteine pools |
| CBS | Cystathionine beta-synthase | Transsulfuration enzyme affecting cysteine supply |
| SHMT1 | Serine hydroxymethyltransferase 1 | One-carbon metabolism linked to cysteine supply |
| SLC1A4 | Neutral amino acid transporter | Contributes to amino acid supply for taurine synthesis |
| SLC1A5 | Glutamine transporter | Supports amino acid pools feeding sulfur metabolism |
| OSR1 | Oxidative stress-responsive kinase | Potential osmotic stress signalling node affecting taurine regulation |
How Is regulation of taurine biosynthetic process Regulated?
Regulation of taurine biosynthetic process is itself regulated at multiple levels. The taurine transporter SLC6A6 is controlled by osmotic stress, hormones and substrate availability, providing feedback on intracellular taurine content. Cellular taurine content is maintained by a balance of synthesis, uptake and efflux, and this balance is adjusted in response to organic osmolyte demand. Systemic signals such as feeding status and obesity-related pathways, including PTER-mediated N-acetyltaurine hydrolysis, further modulate taurine economy. In skeletal muscle, taurine availability influences glucose uptake, tying biosynthetic regulation to insulin-sensitive metabolic signalling. Finally, mitochondrial taurine import via SLC6A6 sustains mitochondrial translation, adding an organelle-level regulatory loop.
regulation of taurine biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC6A6 | Leukaemia, tumour growth | SLC6A6 knockout leukaemia cell line [1,5] |
| PTER | Obesity and feeding regulation | Pter knockout mouse model |
| TP53 | Pancreatic beta-cell senescence | Tp53 point-mutation beta-cell line |
| CDO1 | Cysteine catabolism and metabolic disease | CDO1 knockout hepatocyte model |
| CSAD | Taurine biosynthesis deficiency | CSAD knockout cell model |
Taurine biosynthetic regulation in leukaemia
Taurine from the tumour niche drives glycolysis to promote leukaemogenesis, demonstrating that regulation of taurine availability can be co-opted by malignant cells. This suggests that enzymes and transporters controlling taurine biosynthesis or uptake are potential therapeutic targets in leukaemia.
Obesity and feeding control
PTER is an N-acetyltaurine hydrolase that regulates feeding and obesity, directly linking taurine derivative metabolism to systemic energy balance. Dysregulation of this axis may contribute to obesity and metabolic dysfunction, making it a candidate for metabolic disease research.
Pancreatic beta-cell senescence and diabetes
Taurine alleviates pancreatic beta-cell senescence by inhibiting the p53 pathway, indicating that taurine availability protects beta cells from ageing-related dysfunction. Regulators of taurine biosynthesis could therefore influence diabetes progression.
Tumour mitochondrial translation and growth
SLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth, showing that subcellular taurine distribution is critical for cancer cell proliferation. This expands the disease relevance of GO:0062089 to mitochondrial metabolism in tumours.
From regulation of taurine biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC6A6 reduce taurine biosynthetic flux? | SLC6A6 knockout cell line |
| Does PTER regulate feeding via N-acetyltaurine? | Pter knockout mouse |
| Does a point mutation in TP53 alter taurine protection? | TP53 point-mutation knock-in beta cells |
| Can mitochondrial taurine import be tracked? | SLC6A6 tagged knock-in for imaging |
| Does CSAD overexpression increase taurine output? | CSAD overexpression cell model |
| Which genes control cysteine catabolism? | CRISPR library screening in metabolic cells |
How to Study the regulation of taurine biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Taurine, hypotaurine and N-acetyltaurine levels | Quantify biosynthetic flux [2,3] |
| Radiolabelled uptake assay | SLC6A6 transport activity | Assess transporter regulation |
| CRISPR knockout | Loss-of-function effect on taurine pathway | Test causal regulators |
| CRISPR knock-in | Tagged protein localisation | Image mitochondrial taurine import |
| RNA-seq | Transcriptional changes in pathway genes | Identify regulatory networks |
| Proteomics | Protein abundance and interactions | Discover cysteine catabolism regulators |
| Seahorse glycolysis assay | Glycolytic rate | Link taurine to leukaemia metabolism |
| Senescence assays | Beta-cell senescence markers | Test taurine protection via p53 |
Metabolomics and taurine quantification
Mass spectrometry-based metabolomics is used to quantify taurine and its precursors, providing direct readouts of biosynthetic flux. Covariation mass spectrometry has been applied to uncover proteins controlling cysteine catabolism, a key input to taurine synthesis. Targeted assays for taurine, hypotaurine and N-acetyltaurine allow researchers to test whether candidate regulators change pathway output [2,3].
Transport and uptake assays
Radiolabelled or fluorescent taurine uptake assays measure SLC6A6 activity and its regulation by osmotic stress and hormones. These assays are essential to distinguish changes in biosynthesis from changes in transport when interpreting intracellular taurine levels [7,8].
Genetic perturbation with CRISPR
CRISPR knockout, knock-in and point-mutation models allow causal testing of candidate regulators of taurine biosynthesis. For example, SLC6A6 knockout cells can reveal whether transporter loss alters biosynthetic demand, while Pter knockout mice test systemic effects on feeding and obesity.
Mitochondrial and imaging approaches
Tagged knock-in of SLC6A6 enables imaging of mitochondrial taurine import, which sustains mitochondrial translation and tumour growth. Combining imaging with translation assays helps link subcellular taurine distribution to biosynthetic regulation.
How CRISPR Can Be Used to Study GO:0062089 regulation of taurine biosynthetic process
Knockout
CRISPR knockout of SLC6A6 or biosynthetic enzymes can determine whether loss of function reduces intracellular taurine and alters downstream phenotypes such as mitochondrial translation or tumour growth [5,7]. Knockout models are the first step in establishing causality for GO:0062089 regulators.
Point Mutation
Point-mutation knock-in of TP53 can test whether specific p53 residues mediate taurine-dependent protection against beta-cell senescence. Such models separate catalytic or binding functions from scaffolding roles in taurine regulation.
Knock-in
Tagged knock-in of SLC6A6 allows visualisation of mitochondrial taurine import and its contribution to mitochondrial translation. Knock-in reporters can also track pathway enzyme expression in live cells.
Overexpression
Overexpression of CSAD or other biosynthetic enzymes can test whether increased enzyme abundance raises taurine output and protects cells from stress. Overexpression models complement knockout studies by probing gain of function.
How EDITGENE Supports regulation of taurine biosynthetic process Research
Researchers studying regulation of taurine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in setting taurine flux, rather than merely correlating with it. Rigorous causal inference requires isogenic knockout, point-mutation, knock-in and overexpression models, combined with metabolomic and transport readouts.
Contact EDITGENE today to design your custom CRISPR model for regulation of taurine biosynthetic process research.
Frequently Asked Questions About regulation of taurine biosynthetic process
What is GO:0062089 regulation of taurine biosynthetic process?
GO:0062089 is a Gene Ontology biological_process term defined as any process that modulates the rate, frequency or extent of taurine biosynthesis.
What genes are involved in regulation of taurine biosynthetic process?
Key genes include SLC6A6, PTER, CDO1, CSAD and GADL1, which control taurine transport, derivative hydrolysis and biosynthetic enzyme steps [2,3,7,8].
Why is taurine biosynthesis regulation important in cancer?
Taurine from the tumour niche drives glycolysis to promote leukaemogenesis, and mitochondrial taurine import sustains tumour growth [1,5].
How is taurine transport regulated?
The taurine transporter SLC6A6 is regulated by osmotic stress, hormones and substrate availability, controlling intracellular taurine content.
What is the role of PTER in taurine metabolism?
PTER is an N-acetyltaurine hydrolase that regulates feeding and obesity, linking taurine derivative catabolism to energy balance.
Does taurine affect pancreatic beta cells?
Taurine alleviates pancreatic beta-cell senescence by inhibiting the p53 pathway.
How can I study regulation of taurine biosynthetic process with CRISPR?
CRISPR knockout, knock-in, point-mutation and overexpression models allow causal testing of candidate regulators, combined with metabolomics and transport assays [3,5,7].
What methods measure taurine biosynthetic flux?
LC-MS metabolomics, radiolabelled uptake assays and CRISPR perturbation are commonly used to measure taurine and precursor levels [2,3,7].
Is taurine involved in glucose metabolism?
Taurine regulates glucose uptake in skeletal muscle, connecting its biosynthetic regulation to glucose homeostasis.
What diseases are linked to taurine biosynthetic regulation?
Leukaemia, obesity, pancreatic beta-cell senescence and tumour mitochondrial metabolism have been linked to taurine pathway regulation [1,2,4,5].
Conclusion
GO:0062089 regulation of taurine biosynthetic process captures the control layer that sets the rate of taurine production in cells. It integrates substrate supply from cysteine catabolism, enzymatic conversion, transporter-mediated feedback and systemic metabolic signals [2,3,7,8]. Dysregulation of this process is implicated in leukaemia, obesity, beta-cell senescence and tumour growth, making it a compelling area for functional genomics [1,2,4,5]. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with metabolomics and transport assays, provide the tools needed to move from correlation to causation in taurine biology. EDITGENE supports these efforts with custom cell model generation, library screening and bioinformatics services.
References
- 1. Sharma S et al.. 2025. Taurine from tumour niche drives glycolysis to promote leukaemogenesis.. Nature 644(8075):263-272 PMID: 40369079
- 2. Wei W et al.. 2024. PTER is a N-acetyltaurine hydrolase that regulates feeding and obesity.. Nature 633(8028):182-188 PMID: 39112712
- 3. Xiao H et al.. 2025. Covariation MS uncovers a protein that controls cysteine catabolism.. Nature 647(8088):268-276 PMID: 40963025
- 4. Wang B et al.. 2025. Taurine Alleviates Pancreatic β-Cell Senescence by Inhibition of p53 Pathway.. J Diabetes 17(6):e70100 PMID: 40458841
- 5. Li L et al.. 2026. SLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth.. Nat Metab 8(3):704-721 PMID: 41652173
- 6. Ra SG. 2022. Effect of Taurine on the Regulation of Glucose Uptake in the Skeletal Muscle.. Adv Exp Med Biol 1370:305-309 PMID: 35882805
- 7. Han X et al.. 2006. The taurine transporter: mechanisms of regulation.. Acta Physiol (Oxf) 187(1-2):61-73 PMID: 16734743
- 8. Lambert IH. 2004. Regulation of the cellular content of the organic osmolyte taurine in mammalian cells.. Neurochem Res 29(1):27-63 PMID: 14992263
